Class information for:
Level 1: RALTEGRAVIR//DOLUTEGRAVIR//ETRAVIRINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
7021 1415 33.0 73%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
29 3       HIV//VIROLOGY//HIV 1 108954
773 2             EFAVIRENZ//NEVIRAPINE//RALTEGRAVIR 12242
7021 1                   RALTEGRAVIR//DOLUTEGRAVIR//ETRAVIRINE 1415

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RALTEGRAVIR authKW 2812867 14% 65% 202
2 DOLUTEGRAVIR authKW 1679895 6% 91% 86
3 ETRAVIRINE authKW 1275723 6% 66% 90
4 INTEGRASE INHIBITOR authKW 1248588 9% 48% 121
5 DARUNAVIR authKW 1061935 7% 47% 105
6 ELVITEGRAVIR authKW 910454 4% 74% 57
7 RILPIVIRINE authKW 718651 4% 57% 58
8 COBICISTAT authKW 505754 2% 76% 31
9 INTEGRASE STRAND TRANSFER INHIBITORS authKW 271125 1% 74% 17
10 TREATMENT EXPERIENCED authKW 259406 2% 52% 23

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Infectious Diseases 52773 57% 0% 808
2 Virology 14080 24% 0% 342
3 Pharmacology & Pharmacy 8314 45% 0% 637
4 Immunology 4629 28% 0% 400
5 Microbiology 3776 22% 0% 317
6 Medicine, General & Internal 109 6% 0% 82
7 Toxicology 69 3% 0% 41
8 Medical Laboratory Technology 13 1% 0% 11
9 Biochemical Research Methods 8 2% 0% 26
10 Health Care Sciences & Services 2 1% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HIV UNIT 92241 3% 11% 40
2 HP VIROLU943 77062 0% 71% 5
3 NORTHSTAR MED 64734 0% 100% 3
4 LLUITA SIDA FDN 57275 1% 15% 18
5 HOSP JUAN FERNANDEZ 48549 0% 75% 3
6 ARNAS AZIENDA OSPED RILIEVO NAZL ALTA SPECIALIZ 43156 0% 100% 2
7 CLINICIZZATA MALATTIE INFETT 43156 0% 100% 2
8 COREVIH PAYS DE LA LOIRE 43156 0% 100% 2
9 EMEAC 43156 0% 100% 2
10 GEN HOSP 2 43156 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HIV CLINICAL TRIALS 77695 3% 8% 43
2 ANTIVIRAL THERAPY 51670 5% 4% 67
3 AIDS REVIEWS 44826 2% 9% 24
4 HIV MEDICINE 41763 3% 4% 46
5 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 33509 6% 2% 81
6 AIDS 27572 7% 1% 105
7 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 23600 8% 1% 117
8 AIDS RESEARCH AND HUMAN RETROVIRUSES 8480 3% 1% 46
9 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 7796 7% 0% 93
10 AIDS RESEARCH AND THERAPY 7345 1% 3% 10

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 RALTEGRAVIR 2812867 14% 65% 202 Search RALTEGRAVIR Search RALTEGRAVIR
2 DOLUTEGRAVIR 1679895 6% 91% 86 Search DOLUTEGRAVIR Search DOLUTEGRAVIR
3 ETRAVIRINE 1275723 6% 66% 90 Search ETRAVIRINE Search ETRAVIRINE
4 INTEGRASE INHIBITOR 1248588 9% 48% 121 Search INTEGRASE+INHIBITOR Search INTEGRASE+INHIBITOR
5 DARUNAVIR 1061935 7% 47% 105 Search DARUNAVIR Search DARUNAVIR
6 ELVITEGRAVIR 910454 4% 74% 57 Search ELVITEGRAVIR Search ELVITEGRAVIR
7 RILPIVIRINE 718651 4% 57% 58 Search RILPIVIRINE Search RILPIVIRINE
8 COBICISTAT 505754 2% 76% 31 Search COBICISTAT Search COBICISTAT
9 INTEGRASE STRAND TRANSFER INHIBITORS 271125 1% 74% 17 Search INTEGRASE+STRAND+TRANSFER+INHIBITORS Search INTEGRASE+STRAND+TRANSFER+INHIBITORS
10 TREATMENT EXPERIENCED 259406 2% 52% 23 Search TREATMENT+EXPERIENCED Search TREATMENT+EXPERIENCED

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 PARK, TE , MOHAMED, A , KALABALIK, J , SHARMA, R , (2015) REVIEW OF INTEGRASE STRAND TRANSFER INHIBITORS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 13. ISSUE 10. P. 1195 -1212 59 84% 3
2 KANDEL, CE , WALMSLEY, SL , (2015) DOLUTEGRAVIR - A REVIEW OF THE PHARMACOLOGY, EFFICACY, AND SAFETY IN THE TREATMENT OF HIV.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 9. ISSUE . P. 3547 -3555 53 78% 6
3 ANTINORI, A , MARCOTULLIO, S , ANDREONI, M , CHIRIANNI, A , MONFORTE, AD , DI BIAGIO, A , GALLI, M , MAZZOTTA, F , MUSSINI, C , PUOTI, M , ET AL (2016) ITALIAN GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS AND THE DIAGNOSTIC-CLINICAL MANAGEMENT OF HIV-1 INFECTED PERSONS. UPDATE 2015.NEW MICROBIOLOGICA. VOL. 39. ISSUE 2. P. 93 -109 69 59% 1
4 TAHA, H , DAS, A , DAS, S , (2015) CLINICAL EFFECTIVENESS OF DOLUTEGRAVIR IN THE TREATMENT OF HIV/AIDS.INFECTION AND DRUG RESISTANCE. VOL. 8. ISSUE . P. 339 -352 49 83% 4
5 LLIBRE, JM , PULIDO, F , GARCIA, F , DELTORO, MG , BLANCO, JL , DELGADO, R , (2015) GENETIC BARRIER TO RESISTANCE FOR DOLUTEGRAVIR.AIDS REVIEWS. VOL. 17. ISSUE 1. P. 56 -64 40 91% 11
6 MESPLEDE, T , QUASHIE, PK , ZANICHELLI, V , WAINBERG, MA , (2014) INTEGRASE STRAND TRANSFER INHIBITORS IN THE MANAGEMENT OF HIV-POSITIVE INDIVIDUALS.ANNALS OF MEDICINE. VOL. 46. ISSUE 3. P. 123-129 44 92% 8
7 DEHORITY, W , ABADI, J , WIZNIA, A , VIANI, RM , (2015) USE OF INTEGRASE INHIBITORS IN HIV-INFECTED CHILDREN AND ADOLESCENTS.DRUGS. VOL. 75. ISSUE 13. P. 1483 -1497 50 83% 0
8 KARMON, SL , MARKOWITZ, M , (2013) NEXT-GENERATION INTEGRASE INHIBITORS WHERE TO AFTER RALTEGRAVIR?.DRUGS. VOL. 73. ISSUE 3. P. 213 -228 47 78% 27
9 LIEDTKE, MD , TOMLIN, CR , LOCKHART, SM , MILLER, MM , RATHBUN, RC , (2014) LONG-TERM EFFICACY AND SAFETY OF RALTEGRAVIR IN THE MANAGEMENT OF HIV INFECTION.INFECTION AND DRUG RESISTANCE. VOL. 7. ISSUE . P. 73 -84 43 91% 4
10 MESPLEDE, T , WAINBERG, MA , (2015) RESISTANCE AGAINST INTEGRASE STRAND TRANSFER INHIBITORS AND RELEVANCE TO HIV PERSISTENCE.VIRUSES-BASEL. VOL. 7. ISSUE 7. P. 3703 -3718 44 79% 8

Classes with closest relation at Level 1


Rank Class id link
1 6181 ATAZANAVIR//RITONAVIR//LOPINAVIR
2 545 HIV DRUG RESISTANCE//HIV 1 DRUG RESISTANCE//TRANSMITTED DRUG RESISTANCE
3 12516 EFAVIRENZ//NEVIRAPINE//CYP2B6
4 2499 INTEGRASE//HIV 1 INTEGRASE//LEDGF P75
5 2716 ANTIRETROVIRAL THERAPY//ROYAL FREE HIV MED//CD4 CELL COUNT
6 6847 HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN
7 11702 I TECH SERV//LAMIVUDINE//EMTRICITABINE
8 859 LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB
9 26650 NANOART//PHARMACEUT NANOMAT SCI//PHARMACOL EXPT NEUROSCI
10 15789 HIV MOL GRP//DRUG THERAPY VIROLOGY//HIV

Go to start page